We are proud of Dr. Katie Larson Ode, who is giving an invited lecture today at the European Cystic Fibrosis Society annual Conference in Liverpool, UK. The title of her lecture as “CFRD (cystic fibrosis related diabetes) in the age of correctors”. Dr. Larson Ode is an internationally recognized expert in the care of patients with CFRD. Patients with cystic fibrosis are now being treated with powerful medications that directly restore function of the defective protein that causes their disease. These medications dramatically improve lung function, but their impact on cystic fibrosis related diabetes is less clear. In her talk, Dr. Larson Ode will review available data and discuss ongoing uncertainties.
Dr. Tsalikian Tapped to Become Interim Chair of Pediatrics.
Dr. Tsalikian, who has long headed the Division of Pediatric Endocrinology & Diabetes, has been asked to serve as the interim Chair of Pediatrics at the University of Iowa and as the interim physician-in-chief of University of Iowa Stead Family Children’s Hospital. These requests recognize her strong leadership skills for leading an academic medical department focused on excellent clinical care and advancing treatment and prevention through cutting edge research. Dr. Tsalikian assumed these duties effective June 1, 2019. Dr. Tsalikian received her medical degree from the University of Athens. Her training in endocrinology research was obtained at the University of California San Francisco and at Mayo Clinic. She completed a pediatric residency at Children’s Hospital of Pittsburgh, and a Pediatric Endocrinology Fellowship at Children’s Hospital of Pittsburgh.
Dr. Pesce Recognized for her Outstanding Teaching
Dr. Pesce recently received the Excellence in Clinical Coaching award. This award is given to select faculty who are known for outstanding clinical teaching of resident and fellow physicians. The comments that accompanied the award were “Dr. Pesce has a true passion for teaching and making sure that her patients receive the best care possible. When I have worked with Dr. Pesce, she sat with me one-on-one to review the unique aspects of the patient’s diagnoses and explained why we may be doing things a certain way.”
Does Diabeteic Ketoacidosis Impact Brain Development in Children?
Dr. Tsalikian has helped author a recent manuscript aimed at better understanding whether diabetic ketoacidosis might impact brain development in children. This manuscript was published this month in the prestigious journal Diabetes Care (permanent link to manuscript, link to public free version). They found that children who had experienced moderate-to-severe diabetic ketoacidosis had altered brain dimensions and lower cognitive scores. These results, though only correlative, suggest that moderate-to-severe diabetic ketoacidosis has an adverse impact on the developing brain. Several other of our division members contributed to this work, including Dr. Tansey, along with study coordinators Julie Coffey MSN, Joanne Cabbage, and Sara Salamati.